Yessica Sachdeva, MD
Internal Medicine · Mesa, AZNPI 1730496274
Payments from drug & device makers
Across 1,119 payments — averaging $12,239 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$6.5M
- Eli Lilly$2.9M
- Bavarian Nordic A/s$1.1M
- GSK$537K
- AstraZeneca$501K
- Boehringer Ingelheim$483K
- plus $1.6M from 25 others
Across 11 payments — averaging $5119.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$56K
- Regeneron$607
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 238 | $6,515,468 |
| Eli Lilly | 57 | $2,919,192 |
| Bavarian Nordic A/s | 88 | $1,107,441 |
| GSK | 172 | $536,554 |
| AstraZeneca | 10 | $501,430 |
| Boehringer Ingelheim | 33 | $483,377 |
| Astrazeneca UK Limited | 5 | $400,498 |
| Pfizer | 57 | $358,765 |
| Modernatx, Inc. | 67 | $307,131 |
| Gilead | 52 | $266,687 |
| Boehringer Ingelheim International GmbH | 227 | $178,361 |
| Merck | 7 | $89,675 |
| Boehringer Ingelheim Canada Ltd.ltee | 32 | $21,257 |
| Siemens Medical Solutions USA, Inc. | 1 | $7,350 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $386 |
| AbbVie | 15 | $375 |
| Sanofi-aventis U.S. LLC | 3 | $317 |
| Regeneron Healthcare Solutions, Inc. | 1 | $270 |
| Intra-sana Laboratories | 4 | $268 |
| Madrigal Pharmaceuticals | 12 | $246 |
| Novo Nordisk | 2 | $209 |
| Lilly USA, LLC | 1 | $125 |
| Intercept Pharmaceuticals, Inc. | 5 | $90 |
| Ipsen Biopharmaceuticals, Inc | 3 | $62 |
| Orphalan Inc | 2 | $43 |
| Bayer | 1 | $26 |
| Invivyd Inc | 1 | $24 |
| Eisai Inc. | 1 | $20 |
| Eton Pharmaceuticals, Inc. | 1 | $20 |
| Grifols USA, LLC | 1 | $17 |
| Albireo Pharma, Inc. | 1 | $16 |
How this compares
$13,695,698 in reported general payments places this provider in the 95th percentile of 2,212 internal medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Mesa
- Tami BruceMesa$976K
- Ali ImranMesa$240K
- Louise TaberPhoenix$8.5M
- Janelle WeyerChandler$5.5M
- Robert MutterperlTucson$5.3M
- Jalal AbbasSun City West$4.8M
- Nebojsa SkrepnikTucson$4.7M
- Philip MathewTempe$4.1M
- Justin MoserScottsdale$3.9M
- Franz RischardTucson$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.